[go: up one dir, main page]

BR9914031A - Composições farmacêuticas micronizadas - Google Patents

Composições farmacêuticas micronizadas

Info

Publication number
BR9914031A
BR9914031A BR9914031-4A BR9914031A BR9914031A BR 9914031 A BR9914031 A BR 9914031A BR 9914031 A BR9914031 A BR 9914031A BR 9914031 A BR9914031 A BR 9914031A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
micronized
micronized pharmaceutical
pharmaceutical
sulfometate
Prior art date
Application number
BR9914031-4A
Other languages
English (en)
Other versions
BR9914031B1 (pt
Inventor
Richard Anthony Flynn
Martin Harris Goldman
James Richard Lovely
Original Assignee
Pharmax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10839350&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9914031(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmax Ltd filed Critical Pharmax Ltd
Publication of BR9914031A publication Critical patent/BR9914031A/pt
Publication of BR9914031B1 publication Critical patent/BR9914031B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: <B>"COMPOSIçõES FARMACêUTICAS MICRONIZADAS"<D>. São descritas composições farmacêuticas compreendendo sulfometato de sódio colistina micronizado. A substância farmacêutica micronizada pode ser usada em conjunto com um veículo, tal como lactose. As composições farmacêuticas podem ser embaladas em recipientes, tais como, cápsulas de gelatina, e administradas por inalação do pó.
BRPI9914031-4A 1998-09-23 1999-09-22 partìculas micronizadas de sulfonetato de sódio colistina, composição, forma de dosagem farmacêutica e cápsula compreendendo as mesmas e processo para a preparação da referida composição. BR9914031B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9820746.7 1998-09-23
GBGB9820746.7A GB9820746D0 (en) 1998-09-23 1998-09-23 Micronised pharmaceutical compositions
PCT/GB1999/003172 WO2000016745A2 (en) 1998-09-23 1999-09-22 Micronised pharmaceutical compositions

Publications (2)

Publication Number Publication Date
BR9914031A true BR9914031A (pt) 2001-06-19
BR9914031B1 BR9914031B1 (pt) 2011-02-08

Family

ID=10839350

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI9914031-4A BR9914031B1 (pt) 1998-09-23 1999-09-22 partìculas micronizadas de sulfonetato de sódio colistina, composição, forma de dosagem farmacêutica e cápsula compreendendo as mesmas e processo para a preparação da referida composição.
BRPI9914031A BRPI9914031B8 (pt) 1998-09-23 1999-09-22 partículas micronizadas de sulfometato de sódio colistina, composição, forma de dosagem farmacêutica e cápsula compreendendo as mesmas e processo para a preparação da referida composição.

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI9914031A BRPI9914031B8 (pt) 1998-09-23 1999-09-22 partículas micronizadas de sulfometato de sódio colistina, composição, forma de dosagem farmacêutica e cápsula compreendendo as mesmas e processo para a preparação da referida composição.

Country Status (20)

Country Link
EP (1) EP1115380B2 (pt)
JP (1) JP5165168B2 (pt)
CN (1) CN1148168C (pt)
AT (1) ATE267585T1 (pt)
AU (1) AU752266B2 (pt)
BR (2) BR9914031B1 (pt)
CA (1) CA2341366C (pt)
CZ (1) CZ298603B6 (pt)
DE (1) DE69917658T3 (pt)
DK (1) DK1115380T4 (pt)
EA (1) EA003193B1 (pt)
ES (1) ES2222733T5 (pt)
GB (1) GB9820746D0 (pt)
HU (1) HU228888B1 (pt)
IL (1) IL141913A0 (pt)
MX (1) MXPA01003103A (pt)
NZ (1) NZ509881A (pt)
PL (1) PL197871B1 (pt)
PT (1) PT1115380E (pt)
WO (1) WO2000016745A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129705A1 (en) * 2000-02-17 2001-09-05 Rijksuniversiteit te Groningen Powder formulation for inhalation
AU2004294889B2 (en) * 2003-12-03 2010-08-26 Boehringer Ingelheim International Gmbh Medical product containing tiotropium
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
WO2012061902A1 (en) * 2010-11-12 2012-05-18 Monash University Micronised spray-dried particles comprising polymyxin
AU2014249529B2 (en) * 2013-03-13 2018-08-09 Actavis Group Ptc Ehf Micronized pharmaceutical compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4564614A (en) * 1984-10-11 1986-01-14 Pfizer Inc. Antiinflammatory methods
IT1228459B (it) † 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
GB8911259D0 (en) † 1989-05-17 1989-07-05 Fisons Plc Inhalation medicament
US5916596A (en) † 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
US5875776A (en) † 1996-04-09 1999-03-02 Vivorx Pharmaceuticals, Inc. Dry powder inhaler
CA2242335A1 (en) * 1996-11-15 1998-05-22 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections

Also Published As

Publication number Publication date
HUP0104928A3 (en) 2002-08-28
DK1115380T4 (da) 2008-06-16
CA2341366C (en) 2008-11-18
PL197871B1 (pl) 2008-05-30
EP1115380B2 (en) 2008-03-12
JP5165168B2 (ja) 2013-03-21
CN1148168C (zh) 2004-05-05
ATE267585T1 (de) 2004-06-15
DE69917658T2 (de) 2005-06-09
ES2222733T5 (es) 2008-06-16
MXPA01003103A (es) 2005-02-17
EP1115380A2 (en) 2001-07-18
GB9820746D0 (en) 1998-11-18
DE69917658D1 (de) 2004-07-01
BR9914031B1 (pt) 2011-02-08
WO2000016745A3 (en) 2001-05-10
CN1321082A (zh) 2001-11-07
BRPI9914031B8 (pt) 2019-02-26
AU752266B2 (en) 2002-09-12
IL141913A0 (en) 2002-03-10
JP2002526435A (ja) 2002-08-20
PT1115380E (pt) 2004-10-29
CZ298603B6 (cs) 2007-11-21
WO2000016745A2 (en) 2000-03-30
EA200100253A1 (ru) 2001-08-27
DE69917658T3 (de) 2009-04-02
EP1115380B1 (en) 2004-05-26
ES2222733T3 (es) 2005-02-01
PL346774A1 (en) 2002-02-25
EA003193B1 (ru) 2003-02-27
HUP0104928A2 (hu) 2002-04-29
AU6212299A (en) 2000-04-10
NZ509881A (en) 2003-01-31
DK1115380T3 (da) 2004-10-04
CZ20011050A3 (cs) 2001-09-12
CA2341366A1 (en) 2000-03-30
HU228888B1 (en) 2013-06-28

Similar Documents

Publication Publication Date Title
PL337794A1 (en) Pharmaceutic agent for oral administration containing an active substance and cyclodextrin
DE69940769D1 (de) Orale flüssige zusammensetzungen
BR0015605A (pt) Composição e uso
IL165601A0 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
ATE293995T1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
BR0003158A (pt) Formulação de dosagem oral de derretimentoinstantâneo
PL347671A1 (en) Compounds and compositions for delivering active agents
YU37301A (sh) Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
BR9908815A (pt) Dispositivo de inalação
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
IL141236A0 (en) New oral formulations for 5-ht4 agonists or antagonists
PL373456A1 (en) Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
BR0013106A (pt) Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido.
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
BR9914031A (pt) Composições farmacêuticas micronizadas
FR12C0064I1 (pt)
DK1061938T3 (da) Orale sammensætninger med cytotoksiske proteiner i lav dosis
AP1692A (en) Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent.
MY152490A (en) New oral formulation

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: FOREST LABORATORIES UK LIMITED (GB)

Free format text: ALTERADO DE: PHARMAX LIMITED

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/02/2011, OBSERVADAS AS CONDICOES LEGAIS.

B25G Requested change of headquarter approved

Owner name: FOREST LABORATORIES UK LIMITED (GB)

Free format text: ENDERECO ALTERADO CONFORME SOLICITADO NA PETICAO NO 020110008703/RJ DE 27/01/2011.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/02/2011, OBSERVADAS AS CONDICOES LEGAIS. (CO) REFERENTE A RPI 2092 DE 08/02/2011,QUANTO AOS DESENHOS.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 08.02.2021